slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 12,061-12,090
Pages 1,371
Rows per page 30
Component
12,061-12,090 of 41,127
03
2024 Investor Day2024 Investor Day · MetLife
Consulting deck Strategy consulting Beat · Problem1 hit
02
The chart displays revenue in millions, with a disclaimer about the methodology of geographic apportionment.2024 Q1 Earnings Presentation · Meta
Consulting deck Strategy consulting Beat · Financial HighlightsLoop · Golden Circle1 hit
80
The slide uses a combination of a data table for balance sheet highlights and a combo chart for debt/leverage trends.2025 Investor Day · International Paper
Consulting deck Strategy consulting Beat · SatisfactionLoop · Why Now1 hit
93
Includes a detailed non-GAAP financial measure disclosure at the bottom.2025 Investor Day · International Paper
Consulting deck Strategy consulting 1 hit
94
Includes a detailed non-GAAP financial measure disclaimer at the bottom.2025 Investor Day · International Paper
Consulting deck Strategy consulting 1 hit
95
2025 Investor Day2025 Investor Day · International Paper
Consulting deck Strategy consulting 1 hit
96
Includes a non-GAAP financial measure disclosure at the bottom.2025 Investor Day · International Paper
Consulting deck Strategy consulting 1 hit
09
Includes financial metrics and operational footprint data.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · NeedLoop · Golden Circle1 hit
12
The chart compares indexed CAPEX growth from 2007 to 2025.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · SatisfactionLoop · Golden Circle1 hit
82
The slide highlights the drivers of FCF (resilient markets, working capital, low capex) and provides a financial bridge/table for 2025.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
85
The slide uses a dark blue background with a list of four key financial metrics and their corresponding targets.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
95
Includes detailed footnotes explaining the nature of adjustments (financing income, pension expense, restructuring, M&A costs, D&A).2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
04
Includes both Summit and Akeso trials.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · SolutionLoop · Cost Of Inaction1 hit
06
The table uses a visual bar representation for clinical trial phases (1/1b, 2, 3).2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · ProductLoop · Cost Of Inaction1 hit
07
Includes a table of clinical trials, callout boxes for collaborations and research support, and a forward-looking statement about Q1 2026.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
12
The slide uses a timeline framework to communicate upcoming clinical trial readouts and regulatory events.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
13
The slide highlights a strong liquidity position with significant cash and zero debt.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · FinancialsLoop · Cost Of Inaction1 hit
14
The slide uses a visual flow to aggregate market sizes and point toward future growth areas.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · Market SizeLoop · Cost Of Inaction1 hit
15
2026 Investor Deck2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
01
Includes CEO quote and segment-specific product/category icons.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
08
The slide uses a grid layout to showcase product logos under three main therapeutic pillars.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Solution1 hit
10
The slide uses a grid layout to showcase product logos under three main therapeutic pillars.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Solution1 hit
11
The slide uses a three-column layout to categorize products by medical specialty.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Team1 hit
12
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Team1 hit
14
The table includes a footnote regarding non-GAAP measures and currency impact.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Financials1 hit
19
Includes footnotes regarding non-GAAP measures and segment allocations.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Financials1 hit
22
The table compares two sets of financial guidance projections for the same fiscal year.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
23
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
24
The slide uses a two-column layout to categorize upcoming product milestones.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
28
The slide uses a checkmark symbol to denote achieved milestones.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit